EDGAR Filing Documents for 0001636050-20-000028

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001636050-20-000028

Filing Date

2020-06-10

Accepted

2020-06-09 20:11:29

Documents

Period of Report

2020-03-31

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	axovant3312010k.htm	10-K	2075411
2	EXHIBIT 21.1	axovantexhibit211.htm	EX-21.1	9450
3	EXHIBIT 23.1	axovantexhibit231.htm	EX-23.1	5690
4	EXHIBIT 31.1	axovantexhibit311.htm	EX-31.1	10228
5	EXHIBIT 31.2	axovantexhibit312.htm	EX-31.2	10410
6	EXHIBIT 32.1	axovantexhibit321.htm	EX-32.1	6365
7	EXHIBIT 32.2	axovantexhibit322.htm	EX-32.2	6576
14		alpd.jpg	GRAPHIC	30264
	Complete submission text file	0001636050-20-000028.txt		7086600

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	axon-20200331.xml	EX-101.INS	1028154
9	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	axon-20200331.xsd	EX-101.SCH	52640
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	axon-20200331_cal.xml	EX-101.CAL	78629
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	axon-20200331_def.xml	EX-101.DEF	296746
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	axon-20200331_lab.xml	EX-101.LAB	701240
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	axon-20200331_pre.xml	EX-101.PRE	441041

Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036

Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708

Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37418 | Film No.: 20953253
SIC: 2834 Pharmaceutical Preparations